ABN Amro plans 9.3% reverse exchangeable securities linked to Pfizer

By Laura Lutz

Des Moines, July 3 - ABN Amro Bank NV plans to price 9.3% reverse exchangeable securities due July 30, 2008 linked to the common stock of Pfizer Inc. via LaSalle Financial Services, Inc., according to a term sheet.

The securities will price on July 25 and settle on July 30.

Interest will be payable monthly.

The payout at maturity will be par unless Pfizer stock falls below the knock-in level - 90% of the initial share price - during the life of the securities and finishes below the initial share price, in which case the payout will be a number of Pfizer shares equal to $1,000 divided by the initial share price.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.